AOA Dx
Business Services · Colorado, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
6860 Broadway, Denver, Colorado, 80221, ...Website
www.aoadx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About AOA Dx
AOA's mission is to bring to market the first accurate early stage non-invasive ovarian cancer diagnostic test that will improve clinical practice, help reduce patient mortality and deliver cost savings to payers. The company is based in Boston, MA.Explore more
AOA Dx Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AOA Dx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
AOA Dx, which may be a good buyer, showed buying intent in Masked Content Topic
Check if AOA Dx has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when AOA Dx launches new products
Check out if AOA Dx is spiking on competitors!
Earning: See what the market has to say on AOA Dx recently announced quarterly report
Click to see if AOA Dx had a recent Job posting/layoffs
Funding: Get notified immidiatlly once AOA Dx has new funding data
Congratulate Masked Content for being promoted to Masked Content at AOA Dx
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to AOA Dx
Compare insights from companies similar to AOA Dx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
AOA Dx is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
AOA Dx is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about AOA Dx.
AOA Dx financials insights
Gather financial insights about AOA Dx, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Angel/Seed
$7M
2023
Other Financing Round
$17M
AOA Dx Tech Stack
A closer look at the technologies used by AOA Dx
See more technologies
Most Recent Scoops
New Hire
Executive Move
Christopher Roberts has recently joined the organization as Chief Product Officer. Previously, Roberts served as Chief Product Officer for Arima Genomics.
Executive Moves, New Hire
Funding
Award
Award
Award
Award
Funding
AOA Dx News & Media
AOA Dx Raises $17M in Funding
AOA Dx, a NYC-based company developing a detection test for ovarian cancer, raised $17M in funding. The round was led by Good Growth Capital with participation from RH Capital, Y Combinator, Astia Fund, Adaptive Capital Partners, Gore Range Capital, LongeVC, The Helm, VU Venture Partners, and FemHealth Ventures with diagnostic investors, including Labcorp Venture Fund. […] The post AOA Dx Raises $17M in Funding appeared first on FinSMEs.AOA Dx Closes $7M Funding Round for Ovarian Cancer Test | 360Dx
The firm will use the money to develop its technology for detecting biomarkers of early-stage ovarian cancer through tumor marker gangliosides.3 things to remember when diversifying your startup’s cap table
Making purposeful decisions on diversity and inclusion in the workplace goes beyond simply building your team.
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AOA Dx
Sign Up For FreeTo access detailed company insights
AOA's mission is to bring to market the first accurate early stage non-invasive ovarian cancer diagnostic test that will improve clinical practice, help reduce patient mortality and deliver cost savings to payers. The company is based in Boston, MA.... Read More
